30 November 2022 | News
Akums enters into a joint association with Leiutis and Biophore
To leverage the research expertise and combined manufacturing capacities for introducing first-of-its-kind products in India, New Delhi-based contract development and manufacturing organisation (CDMO), Akums Drugs & Pharmaceuticals has partnered with Leiutis Pharmaceuticals LLP and Biophore India Pharmaceuticals (both based in Hyderabad) for research and development of a range of products for multiple therapies.
This association is set to bring succour in therapy areas of central nervous system (CNS) disorders, pain management, and hormonal disorders, where there is a gap in meeting the needs of patients in an effective, safe, and convenient manner. This partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value proposition to doctors and patients in India.
The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas, within the next five years, both in India and other global markets and with the first few products expected to be commercialised in the next two years.
The agreement was signed at the CPHI event and exhibition on the 30th of November 2022 at Greater Noida in the presence of Prof (Dr) Y.K Gupta, President AIIMS Bhopal & President AIIMS Jammu & Former Dean & HoD Pharmacology, AIIMS Delhi.